Ken Aoshima currently serves as a Director at Eisai, where responsibilities include providing innovative study designs and statistical methods for Clinical Development Plans, Protocols, and Statistical Analysis Plans, alongside ensuring high-quality analysis for Clinical Study Reports and regulatory submissions. Previously, Ken held the position of Director, Head of Tsukuba Biomarker & Personalized Medicine, focusing on biomarker-based mechanisms of action research, and succeeded in achieving proof-of-mechanism based on biomarkers. Earlier in the career at Eisai, Ken worked as a Senior Scientist, developing an in-house compound database and analysis methods in Genomics, Proteomics, and Metabolomics. Prior experience includes serving as Senior Director at Mitsui Knowledge Industry, where Ken specialized in Clinical Informatics, Bioinformatics, and Computational Biology, contributing to diagnosis and drug discovery applications. Ken Aoshima holds a Ph.D. and a combined Bachelor’s and Master’s degree in Applied Physics from the Tokyo Institute of Technology.
This person is not in any teams
This person is not in any offices